)
)
)
Vincere Biosciences Inc
March 02, 2026
Ballroom I C
Type: Company Presentation
Focus Area:
CNS/Neurological
Vincere Biosciences is a Boston-based, AI-powered biotechnology company developing first-in-class therapeutics that target the fundamental mechanisms of aging and disease. By enhancing mitophagy—the cell’s natural system for clearing damaged mitochondria—Vincere aims to stop the progression of Parkinson’s disease and other age-related conditions at their root. Powered by a proprietary virtual cell platform and rigorous, mechanism-driven science, Vincere is building a patent-protected pipeline of transformative medicines designed not just to treat symptoms, but to meaningfully improve and extend human life
Year Founded:
2018
Lead Product in Development:
Selective USP30 inhibitor (oral) being advanced as the development candidate for Parkinson’s disease
Speakers
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
